"Designing Growth Strategies is in our DNA"

Anti-Inflammatory Biologics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, and Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI102733

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Rheumatoid Arthritis & Psoriasis – For Key Countries
    2. Pipeline Analysis
    3. Patent Snapshot
    4. New Product Launches
    5. Key Industry Developments - Mergers, Acquisitions and Partnerships
  5. Global Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2022-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2022-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2022-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2022-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2022-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub regions
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2022-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles
      1. AbbVie Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      3. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      4. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      5. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      6. Novartis AG
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      7. UCB S.A.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      8. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      9. Amgen Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      10. Biogen
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
Read Less

Figure 1: Global Anti-inflammatory Biologics Market Revenue Breakdown (USD Billion, %) by Region, 2022 & 2030

Figure 2: Global Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2022 & 2030

Figure 3: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Anti-Tumor Necrosis Factor (TNF), 2022-2030

Figure 4: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Interleukin Antagonists, 2022-2030

Figure 5: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Janus Kinase (JAK) Inhibitors, 2022-2030

Figure 6: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Others, 2022-2030

Figure 7: Global Anti-inflammatory Biologics Market Value Share (%), by Application, 2022 & 2030

Figure 8: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Rheumatoid Arthritis, 2022-2030

Figure 9: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Psoriasis, 2022-2030

Figure 10: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Others, 2022-2030

Figure 11: Global Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2022 & 2030

Figure 12: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Oral, 2022-2030

Figure 13: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Injection, 2022-2030

Figure 14: Global Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 15: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Hospital Pharmacy, 2022-2030

Figure 16: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Retail Pharmacy, 2022-2030

Figure 17: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Online Pharmacy, 2022-2030

Figure 18: Global Anti-inflammatory Biologics Market Value (USD Billion), by Region, 2022 & 2030

Figure 19: North America Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2022 & 2030

Figure 20: North America Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2022

Figure 21: North America Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2022 & 2030

Figure 22: North America Anti-inflammatory Biologics Market Value Share (%), by Application, 2022

Figure 23: North America Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2022 & 2030

Figure 24: North America Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2022

Figure 25: North America Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2022 & 2030

Figure 26: North America Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2022

Figure 27: North America Anti-inflammatory Biologics Market Value (USD Billion), By Country, 2022 & 2030

Figure 28: North America Anti-inflammatory Biologics Market Value Share (%), By Country, 2022

Figure 29: Europe Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2022 & 2030

Figure 30: Europe Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2022

Figure 31: Europe Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2022 & 2030

Figure 32: Europe Anti-inflammatory Biologics Market Value Share (%), by Application, 2022

Figure 33: Europe Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2022 & 2030

Figure 34: Europe Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2022

Figure 35: Europe Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2022 & 2030

Figure 36: Europe Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2022

Figure 37: Europe Anti-inflammatory Biologics Market Value (USD Billion), By Country/ Sub-region, 2022 & 2030

Figure 38: Europe Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2022

Figure 39: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2022 & 2030

Figure 40: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2022

Figure 41: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2022 & 2030

Figure 42: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Application, 2022

Figure 43: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2022 & 2030

Figure 44: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2022

Figure 45: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2022 & 2030

Figure 46: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2022

Figure 47: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), By Country/ Sub-region, 2022 & 2030

Figure 48: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2022

Figure 49: Latin America Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2022 & 2030

Figure 50: Latin America Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2022

Figure 51: Latin America Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2022 & 2030

Figure 52: Latin America Anti-inflammatory Biologics Market Value Share (%), by Application, 2022

Figure 53: Latin America Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2022 & 2030

Figure 54: Latin America Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2022

Figure 55: Latin America Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2022 & 2030

Figure 56: Latin America Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2022

Figure 57: Latin America Anti-inflammatory Biologics Market Value (USD Billion), By Country/ Sub-region, 2022 & 2030

Figure 58: Latin America Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2022

Figure 59: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2022 & 2030

Figure 60: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2022

Figure 61: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2022 & 2030

Figure 62: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Application, 2022

Figure 63: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2022 & 2030

Figure 64: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2022

Figure 65: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2022 & 2030

Figure 66: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2022

Figure 67: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), By Country/ Sub-region, 2022 & 2030

Figure 68: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2022

Figure 69: Global Anti-inflammatory Biologics Market Share (%), By Company, 2022

Table 1: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2022–2030

Table 2: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2022–2030

Table 3: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2022–2030

Table 4: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2022–2030

Table 5: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2022–2030

Table 6: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Region, 2022-2030

Table 7: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2022-2030

Table 8: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2022-2030

Table 9: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2022-2030

Table 10: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2022–2030

Table 11: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2022-2030

Table 12: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country, 2022-2030

Table 13: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2022-2030

Table 14: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2022-2030

Table 15: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2022-2030

Table 16: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2022–2030

Table 17: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2022-2030

Table 18: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2022-2030

Table 19: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2022-2030

Table 20: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2022-2030

Table 21: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2022-2030

Table 22: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2022–2030

Table 23: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2022-2030

Table 24: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2022-2030

Table 25: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2022-2030

Table 26: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2022-2030

Table 27: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2022-2030

Table 28: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2022–2030

Table 29: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2022-2030

Table 30: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2022-2030

Table 31: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2022-2030

Table 32: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2022-2030

Table 33: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2022-2030

Table 34: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2022–2030

Table 35: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2022-2030

Table 36: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2022-2030

Anti-Inflammatory Biologics Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 145
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase